Germany
I am a corporate affairs leader and trusted advisor with 20+ years of experience guiding organizations through transformation, crisis and growth. I’ve held leadership roles at global corporations and innovative biotechs, leading integrated communications, public affairs and advocacy strategies that supported access to innovation, critical business transactions and thought leadership initiatives. Energized by bringing bold ideas to life and unlocking potential in others, I combine strategic vision with hands-on execution to find solutions and create lasting value in complex, fast-moving environments.
Led corporate and product communications, government affairs and policy, as well as corporate responsibility for GSK’s Germany business.
Took a sabbatical to focus on personal projects and pursue long-term goals.
- Led corporate, product and internal communications, investor relations, corporate responsibility, sustainability and patient advocacy - Strengthened corporate equity story and oversaw communications and investor relations throughout the €2.7B acquisition by Novartis, navigating the complexity of a dual Germany/U.S. listing - Provided strategic counsel to the CEO and Executive Committee
- Oversaw results disclosure for company’s lead investigational asset, resulting in successful capital raise of €102.7M - Launched MorphoSys’ MOR Community Connections program to share experiences and challenges in treating and living with cancer - Spearheaded MorphoSys’ Myelofibrosis Patient and Caregiver Insights Council, providing direct engagement between patients and caregivers with senior leaders - Championed social media employee ambassador and engagement program, significantly expanding reach of corporate social media channels
- Built MorphoSys’ first integrated communications function - Led communications of MorphoSys’ $1.7B acquisition and integration of Constellation Pharmaceuticals - Developed and launched MorphoSys’ new mission and brand identity to reflect its transformation to a development and commercial-stage biotech company with a sole focus on oncology - Overhauled corporate culture through transparent communication and dynamic engagement activities - Founded MorphoSys’ first LGBTQ+ employee and ally network
- Oversaw product, corporate and internal communications for Pfizer’s growing portfolio of oncology medicines, leading a team across the U.S. and Europe - Provided strategic counsel to the Global President of Pfizer's oncology division, building his executive equity platform and driving his internal and external activations - Led communications of Pfizer’s $11B acquisition and integration of Array Biopharma - Partnered with Patient Advocacy, Policy and Government Relations teams to execute cross-functional corporate Affairs programming addressing key issues, including health equity, drug pricing and intellectual property - Served on steering committee of Pfizer’s global LGBTQ+ employee and ally network
- Served as U.S. and international media spokesperson, setting global strategy and directed activations across Pfizer’s Essential Medicines business, spanning 500+ medicines worldwide - Developed and maintained relationships with top tier business, trade and medical news outlets - Mitigated several issues on medicine shortages, recalls and adverse events, ensuring balanced reporting - Designed and co-lead integrated Public Affairs campaign to drive education, legislative change and broader adoption of biosimilars in the U.S.
- Oversaw corporate, product, policy and digital communications for Pfizer’s Germany affiliate - Provided strategic counsel to Country Manager and developed his thought leadership platform - Co-founded and supervised Pfizer’s Berlin Healthcare Hub, establishing key partnerships with digital health start-ups - Co-created and chaired colleague resource networks supporting diversity and inclusion efforts in Pfizer across Europe, including support for LGBTQ+ colleagues and their allies